EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antimalarial mass drug administration in large populations and the evolution of drug resistance

Tran Dang Nguyen iD, Thu Nguyen-Anh Tran iD, Daniel M Parker iD, Nicholas J White iD, Maciej F Boni iD

PLOS Global Public Health · 26.07.2023 · 3 (7) · e0002200

DOI: 10.1371/journal.pgph.0002200 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Global Public Health, online erschienen am 26.07.2023. Verfasst von Tran Dang Nguyen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Infectious Disease Dynamics, Department of Biology, Pennsylvania State University, PA, United States of America. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Bill and Melinda Gates Foundation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mass drug administration (MDA) with antimalarials has been shown to reduce prevalence and interrupt transmission in small populations, in populations with reliable access to antimalarial drugs, and in populations where sustained improvements in diagnosis and treatment are possible. In addition, when MDA is effective it eliminates both drug-resistant parasites and drug-sensitive parasites, which has the long-term benefit of extending the useful therapeutic life of first-line therapies for all populations, not just the focal population where MDA was carried out. However, in order to plan elimination measures effectively, it is necessary to characterize the conditions under which failed MDA could exacerbate resistance. We use an individual-based stochastic model of Plasmodium falciparum transmission to evaluate this risk for MDA using dihydroartemisinin-piperaquine (DHA-PPQ), in populations where access to antimalarial treatments may not be uniformly high and where re-importation of drug-resistant parasites may be common. We find that artemisinin-resistance evolution at the kelch13 locus can be accelerated by MDA when all three of the following conditions are met: (1) strong genetic bottlenecking that falls short of elimination, (2) re-importation of artemisinin-resistant genotypes, and (3) continued selection pressure during routine case management post-MDA. Accelerated resistance levels are not immediate but follow the rebound of malaria cases post-MDA, if this is allowed to occur. Crucially, resistance is driven by the selection pressure during routine case management post-MDA and not the selection pressure exerted during the MDA itself. Second, we find that increasing treatment coverage post-MDA increases the probability of local elimination in low-transmission regions (prevalence < 2%) in scenarios with both low and high levels of drug-resistance importation. This emphasizes the importance of planning for and supporting high coverage of diagnosis and treatment post-MDA.

Autor:innen und Institutionen

  • Center for Infectious Disease Dynamics, Department of Biology, Pennsylvania State University, PA, United States of America.
  • Department of Population Health and Disease Prevention, Department of Epidemiology and Biostatistics, University of California, Irvine, Irvine, CA, United States of America.
  • Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Mahidol-Oxford Research Unit, Wellcome Trust Major Overseas Programme, Mahidol University, Bangkok, Thailand.

ORCID-Profile: Tran Dang Nguyen, Thu Nguyen-Anh Tran, Daniel M Parker, Nicholas J White, Maciej F Boni

Förderung

  • NIAID NIH HHS
  • Bill and Melinda Gates Foundation
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Zitieren

APA

Nguyen, T. D., Tran, T. N., Parker, D. M., White, N. J., & Boni, M. F. (2023). Antimalarial mass drug administration in large populations and the evolution of drug resistance. PLOS Global Public Health, 3(7), e0002200. https://doi.org/10.1371/journal.pgph.0002200

Vancouver

Nguyen TD, Tran TN, Parker DM, White NJ, Boni MF. Antimalarial mass drug administration in large populations and the evolution of drug resistance. PLOS Global Public Health. 2023;3(7):e0002200. doi:10.1371/journal.pgph.0002200

BibTeX
@article{Nguyen2023,
  author = {Nguyen, Tran Dang and Tran, Thu Nguyen-Anh and Parker, Daniel M and White, Nicholas J and Boni, Maciej F},
  title = {Antimalarial mass drug administration in large populations and the evolution of drug resistance},
  journal = {PLOS Global Public Health},
  year = {2023},
  volume = {3},
  number = {7},
  pages = {e0002200},
  doi = {10.1371/journal.pgph.0002200}
}
Kostenlos starten →